theranos Calls on President Trump to Pardon Suresh “Sunny” Balwani

June 30, 2025 11:49 AM PDT | By EODHD
 theranos Calls on President Trump to Pardon Suresh “Sunny” Balwani
Image source: Kalkine Media
Theranos PALM BEACH, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- After calling on President Trump last Friday to pardon Elizabeth Holmes, Ryan ElHosseiny, current CEO and inventor behind the revived theranos, now also urges the President to pardon Ramesh “Sunny” Balwani. ElHosseiny, who re-launched the theranos brand earlier this year, has taken over the name and mission, replicating the technology. “I watched nearly eight hours of the SEC deposition. Everything this man said is factual. Every problem the lab industry has, theranos solved,” said ElHosseiny.

Sunny Balwani referred to commercial analyzers as “clunkers” during his SEC testimony, a statement ElHosseiny strongly agrees with, particularly in regard to Siemens machines. “Before theranos, I ran the first lab in the U.S. to install the Siemens Atellica System in 2018. For at least five years, we dealt with Siemens engineers practically living in our lab due to constant breakdowns. You can read reviews on Reddit from hospitals and labs describing the Atellica system as ‘hell on earth’ and wishing they had chosen another manufacturer.” theranos, like performance brands in other industries, modified its commercial analyzers to improve their reliability and performance.

ElHosseiny draws a direct comparison: “Just as Brabus modifies Mercedes-Benz vehicles and Taran Tactical customizes Glock pistols, theranos upgraded Siemens machines to improve their performance,” ElHosseiny said. “Brabus takes an already solid Mercedes and transforms it into a high-performance vehicle.” Both Brabus and Taran Tactical proudly place their logos on their modified products, and so did theranos. “We didn’t modify for fun—we had to. And every test was validated as an LDT (Laboratory Developed Test) under CLIA regulation,” ElHosseiny explains. “We didn’t ‘hack’ anything, as falsely claimed by Wall Street Journal journalist, John Carreyrou.

The Siemens Advia 1800, for example, is an ‘open channel’ instrument. That means I can load reagents from other manufacturers and program protocols to run custom testing workflows. So the hacking myth is exactly that, a myth.” ElHosseiny has been traveling across the country with JustBlood.com and recently revived the company theranos last month. Since then, the company has gone viral, gaining a large following after announcing the discovery of critical safety concerns involving the pharmaceutical drug Avastin. According to ElHosseiny, the company’s findings echo long-standing concerns raised by RFK Jr., Director of the Department of Health and Human Services.

“We are here to support MAHA, not just in word but through real action, by pressing for transparency and accountability in the regulatory process. Protecting America’s public health is our shared mission,” ElHosseiny said. “Our work highlights critical safety concerns, and we’re committed to doing everything in our power to save lives.” In a personal statement, ElHosseiny adds: Leer más “Mr. President, both Sunny Balwani and Elizabeth Holmes dedicated themselves to the mission of theranos. This work isn’t easy, I’ve been in it for over four years.

theranos is echoing what you and RFK Jr. are fighting for: to fix a flawed healthcare system. Please set them free, not just because I asked, but because the work I’ve published proves they are both innocent and made real contributions to the United States of America. Thank you, sir. Over and out.” ElHosseiny has released a new documentary, The Inventors, now streaming on the theranos website: www.theranoslabs.com Media Contact: Ryan ElHosseiny, [email protected] Ver comentarios


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next